IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v6y2015i1d10.1038_ncomms9327.html
   My bibliography  Save this article

Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation

Author

Listed:
  • E. Suzanne Cohen

    (Inflammation and Autoimmunity, MedImmune Ltd)

  • Ian C. Scott

    (Inflammation and Autoimmunity, MedImmune Ltd)

  • Jayesh B. Majithiya

    (Inflammation and Autoimmunity, MedImmune Ltd)

  • Laura Rapley

    (Inflammation and Autoimmunity, MedImmune Ltd)

  • Benjamin P. Kemp

    (MedImmune Ltd)

  • Elizabeth England

    (MedImmune Ltd)

  • D. Gareth Rees

    (MedImmune Ltd)

  • Catherine L. Overed-Sayer

    (Inflammation and Autoimmunity, MedImmune Ltd)

  • Joanne Woods

    (Inflammation and Autoimmunity, MedImmune Ltd)

  • Nicholas J. Bond

    (Analytical Biotechnology, MedImmune Ltd)

  • Christel Séguy Veyssier

    (Analytical Biotechnology, MedImmune Ltd)

  • Kevin J. Embrey

    (Innovative Medicines, AstraZeneca, Mereside)

  • Dorothy A. Sims

    (Inflammation and Autoimmunity, MedImmune LLC)

  • Michael R. Snaith

    (MedImmune Ltd)

  • Katherine A. Vousden

    (MedImmune Ltd)

  • Martin D. Strain

    (MedImmune Ltd)

  • Denice T. Y. Chan

    (MedImmune Ltd)

  • Sara Carmen

    (MedImmune Ltd)

  • Catherine E. Huntington

    (MedImmune Ltd)

  • Liz Flavell

    (Innovative Medicines, AstraZeneca, Mereside)

  • Jianqing Xu

    (MedImmune Ltd)

  • Bojana Popovic

    (MedImmune Ltd)

  • Christopher E. Brightling

    (Immunity and Inflammation, Institute for Lung Health, Leicester LE3 9QP, UK; NIHR Respiratory Biomedical Research Unit, University Hospitals of Leicester
    NIHR Respiratory Biomedical Research Unit, University Hospitals of Leicester)

  • Tristan J. Vaughan

    (MedImmune Ltd)

  • Robin Butler

    (MedImmune Ltd)

  • David C. Lowe

    (MedImmune Ltd)

  • Daniel R. Higazi

    (Analytical Biotechnology, MedImmune Ltd)

  • Dominic J. Corkill

    (Inflammation and Autoimmunity, MedImmune Ltd)

  • Richard D. May

    (Inflammation and Autoimmunity, MedImmune Ltd)

  • Matthew A. Sleeman

    (Inflammation and Autoimmunity, MedImmune Ltd)

  • Tomas Mustelin

    (Inflammation and Autoimmunity, MedImmune LLC)

Abstract

In response to infections and irritants, the respiratory epithelium releases the alarmin interleukin (IL)-33 to elicit a rapid immune response. However, little is known about the regulation of IL-33 following its release. Here we report that the biological activity of IL-33 at its receptor ST2 is rapidly terminated in the extracellular environment by the formation of two disulphide bridges, resulting in an extensive conformational change that disrupts the ST2 binding site. Both reduced (active) and disulphide bonded (inactive) forms of IL-33 can be detected in lung lavage samples from mice challenged with Alternaria extract and in sputum from patients with moderate–severe asthma. We propose that this mechanism for the rapid inactivation of secreted IL-33 constitutes a ‘molecular clock’ that limits the range and duration of ST2-dependent immunological responses to airway stimuli. Other IL-1 family members are also susceptible to cysteine oxidation changes that could regulate their activity and systemic exposure through a similar mechanism.

Suggested Citation

  • E. Suzanne Cohen & Ian C. Scott & Jayesh B. Majithiya & Laura Rapley & Benjamin P. Kemp & Elizabeth England & D. Gareth Rees & Catherine L. Overed-Sayer & Joanne Woods & Nicholas J. Bond & Christel Sé, 2015. "Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation," Nature Communications, Nature, vol. 6(1), pages 1-10, November.
  • Handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9327
    DOI: 10.1038/ncomms9327
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms9327
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/ncomms9327?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9327. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.